{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:37:46Z","timestamp":1761824266081,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jtcvsonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jtcvs.2020.03.171","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T17:39:03Z","timestamp":1590946743000},"page":"1331-1345.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"160","author":[{"given":"Jessica S.","family":"Donington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark J.","family":"Krasna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quynh-Thu","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohan","family":"Suntharalingam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Billy W.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2020.03.171_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1200\/JCO.2014.59.2360","article-title":"Definitive and adjuvant radiotherapy in locally advanced non-small-cell lung cancer: American Society of Clinical Oncology clinical practice guideline endorsement of the American Society for Radiation Oncology evidence-based clinical practice guideline","volume":"33","author":"Bezjak","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib3","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1200\/JCO.1999.17.9.2692","article-title":"Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer","volume":"17","author":"Furuse","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-5223(19)33853-X","article-title":"Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial","volume":"105","author":"Rusch","year":"1993","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1067\/mtc.2001.112465","article-title":"Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160)","volume":"121","author":"Rusch","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0140-6736(09)60737-6","article-title":"Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial","volume":"374","author":"Albain","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib7","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejcts.2008.12.029","article-title":"Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival","volume":"35","author":"Cerfolio","year":"2009","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.athoracsur.2004.04.085","article-title":"Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer","volume":"78","author":"Sonett","year":"2004","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib10","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1200\/JCO.2010.31.7875","article-title":"Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA\/B non-small-cell lung cancer: RTOG 0324","volume":"29","author":"Blumenschein","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib11","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1200\/JCO.2010.33.4979","article-title":"Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: cancer and Leukemia Group B trial 30407","volume":"29","author":"Govindan","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijrobp.2011.11.069","volume":"84","author":"Suntharalingam","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jtho.2017.06.007","article-title":"Randomized phase II study of preoperative chemoradiotherapy \u00b1 panitumumab followed by consolidation chemotherapy in potentially operable locally advnced (stage IIIA, N2+) non\u2013small cell lung cancer (LANSCLC): NRG oncology\/RTOG 0839","volume":"12","author":"Edelman","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib14","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/jnci\/86.9.673","article-title":"A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer","volume":"86","author":"Roth","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib15","first-page":"28","article-title":"A randomized trial of mitomycin\/ifosfamide\/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer","volume":"21","author":"Rosell","year":"1994","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijrobp.2015.01.032","article-title":"Relationship between radiation therapy dose and outcome in patients treated with neoadjuvant chemoradiation therapy and surgery for stage IIIa non-small cell lung cancer: a population-based, comparative effectiveness analysis","volume":"92","author":"Sher","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib17","doi-asserted-by":"crossref","first-page":"34388","DOI":"10.1038\/srep34388","article-title":"Neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for resectable stage III non-small-cell lung cancer: a meta-analysis","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2015.03.075","article-title":"Higher versus standard preoperative radiation in the trimodality treatment of stage IIIA lung cancer","volume":"100","author":"Bharadwaj","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0003-4975(01)02995-2","article-title":"Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy","volume":"72","author":"Martin","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.athoracsur.2009.08.069","article-title":"Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation","volume":"89","author":"Krasna","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib21","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ejcts\/ezu504","article-title":"Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer","volume":"48","author":"Darling","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib22","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1200\/JCO.2015.62.6812","article-title":"Phase III study of surgery versus definitive concurrent chemoradiotherapy boost in patients with resectable stage IIIA(N2) and selected IIIB non-small-cell lung cancer after induction chemotherapy and concurrent chemoradiotherapy (ESPATUE)","volume":"33","author":"Eberhardt","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib23","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(15)60294-X","article-title":"Induction chemoradiation in stage IIIA\/N2 non-small-cell lung cancer: a phase 3 randomised trial","volume":"386","author":"Pless","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.athoracsur.2012.03.054","article-title":"The Society of Thoracic Surgeons General Thoracic Surgery Database: establishing generalizability to national lung cancer resection outcomes","volume":"94","author":"LaPar","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.athoracsur.2016.02.098","article-title":"The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: higher quality data and superior outcomes","volume":"102","author":"Fernandez","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00268-012-1472-9","article-title":"Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer","volume":"36","author":"Cho","year":"2012","journal-title":"World J Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib27","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jtcvs.2015.01.063","article-title":"Failure to rescue and pulmonary resection for lung cancer","volume":"149","author":"Farjah","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1510\/icvts.2005.118703","article-title":"Risk-adjusted morbidity, mortality and failure-to-rescue models for internal provider profiling after major lung resection","volume":"5","author":"Brunelli","year":"2006","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib29","doi-asserted-by":"crossref","first-page":"8464905","DOI":"10.1155\/2017\/8464905","article-title":"Chemotherapy plus cetuximab versus chemotherapy alone for patients with KRAS wild type unresectable liver-confined metastases colorectal cancer: an updated meta-analysis of RCTs","volume":"2017","author":"Lv","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib30","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1748-717X-6-177","article-title":"Radiotherapy and \u201cnew\u201d drugs-new side effects?","volume":"6","author":"Niyazi","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib31","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","article-title":"Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer","volume":"28","author":"Up\u00e9rin","year":"2010","journal-title":"J Clin Oncol"},{"issue":"Suppl","key":"10.1016\/j.jtcvs.2020.03.171_bib32","first-page":"S129","article-title":"Impact of incidental cardiac irradiation on cardiopulmonary toxicity and survival for locally advanced NSCLC: reanalysis of NRG Oncology RTOG 0617 with centrally contoured cardiac structures","volume":"96","author":"Gore","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib34","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamaoncol.2016.4280","article-title":"Comparison of concurrent use of thoracic radiation with either carboplatin-paclitaxel or cisplatin-etoposide for patients with stage III non-small-cell lung cancer: a systematic review","volume":"3","author":"Steuer","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtcvs.2020.03.171_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2014.56.2587","article-title":"Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data","volume":"33","author":"Santana-Davila","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320312769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522320312769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T17:09:09Z","timestamp":1758388149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522320312769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0022522320312769"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.171","relation":{},"ISSN":["0022-5223"],"issn-type":[{"type":"print","value":"0022-5223"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Thoracic and Cardiovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtcvs.2020.03.171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery","name":"copyright","label":"Copyright"}]}}